Use of the concentration gradient diffusion assay (Etest) for susceptibility testing of anaerobes, fungi, and Mycobacterium spp.

Clinical Microbiology Newsletter

Volumn 24, Issue 14, 2002, Pages 105-109

  Hall, Gerri S ^a   Parshall, Sharon ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CLINDAMYCIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN; TROVAFLOXACIN;

AGAR GEL DIFFUSION; ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CLINICAL LABORATORY; CONCENTRATION GRADIENT DIFFUSION ASSAY; DRUG SCREENING; FUNGUS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

EID: 0037100688     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(02)80027-7     Document Type: Article

References (29)

1. Quantitative antimicrobial susceptibility testing of H. influenzae and S. pneumoniae by using the E-test
2. Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin
3. Comparison of the E test and microdilution for detection of β-lactam-resistant mutants that are stably derepressed for type 1 β-lactamase
4. Evaluation of Etest for susceptibility testing of multidrug-resistant M. tuberculosis
5. Testing of M. tuberculosis susceptibility to ethambutol, INH, rifampin, and streptomycin by using Etest
6. Antimicrobial susceptibility of Mycobacterium marinum determined by Etest and agar dilution
7. Etest for susceptibility testing of M. tuberculosis and M. avium-intracellulare
8. Etest for routine clinical antimicrobial susceptibility testing of rapid growing mycobacteria species
9. Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria
10. Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum
11. Susceptibility testing of anaerobes with Etest
12. Evaluation of the E test for susceptibility testing of anaerobic bacteria
13. Evaluation of the Etest for susceptibility testing of anaerobic bacteria
14. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole
15. Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole
16. Etest for antifungal susceptibility testing of yeasts
17. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media
18. Evaluation of the Etest method for determining voriconazole susceptibility of 312 clinical isolates of Candida species by using three different agar media
19. Multi-centre evaluation of the Etest MIC method for antifungal drug susceptibility testing of Candida spp. and C. neoformans
20. Comparison of Etest and NCCLS broth macrodilution method for antifungal susceptibility testing: Enhanced ability to detect amphotericin-B resistant Candida isolates
21. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: Performances of three different media by using E-test and NCCLS M27-A methodologies
22. Comparison of the Etest with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi
23. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy
24. Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: Results from a multicenter prospective study of candidemia
25. Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures